Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wild

Showing results (621-630 of 738) with videos related to

Pageof 74
Sort By:
The Journal of Pathology|June 3, 2026
Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancerChristoph Steup, Julian Dosch, Christopher Dietz-Fricke, et al.
Neuropsychologia|April 15, 2008
Defective emotion recognition in early HD is neuropsychologically and anatomically genericSusie M D Henley, Edward J Wild, Nicola Z Hobbs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2022
Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinomaMaximilian N Kinzler, Angelika Stehle, Falko Schulze, et al.
European Urology|November 17, 2009
The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progressionJames W F Catto, Maysam F Abbod, Peter J Wild, et al.
The Journal of Clinical Investigation|March 10, 2015
A versatile modular vector system for rapid combinatorial mammalian geneticsJoachim Albers, Claudia Danzer, Markus Rechsteiner, et al.
Plos One|July 15, 2011
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerLotta von Boehmer, Lukas Keller, Ashkan Mortezavi, et al.
BMC Bioinformatics|January 3, 2023
Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathologyYauheniya Zhdanovich, Jörg Ackermann, Peter J Wild, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2015
Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancerBert-Ram Sah, Irene A Burger, Roger Schibli, et al.
Science Translational Medicine|September 14, 2018
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's diseaseLauren M Byrne, Filipe B Rodrigues, Eileanor B Johnson, et al.
Histopathology|February 27, 2024
Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinomaMaximilian N Kinzler, Falko Schulze, Jan Jeroch, et al.
Pageof 74

Showing results (621-630 of 738) with videos related to

Sort By:
Pageof 74
The Journal of Pathology|June 3, 2026
Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancerChristoph Steup, Julian Dosch, Christopher Dietz-Fricke, et al.
Neuropsychologia|April 15, 2008
Defective emotion recognition in early HD is neuropsychologically and anatomically genericSusie M D Henley, Edward J Wild, Nicola Z Hobbs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 25, 2022
Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinomaMaximilian N Kinzler, Angelika Stehle, Falko Schulze, et al.
European Urology|November 17, 2009
The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progressionJames W F Catto, Maysam F Abbod, Peter J Wild, et al.
The Journal of Clinical Investigation|March 10, 2015
A versatile modular vector system for rapid combinatorial mammalian geneticsJoachim Albers, Claudia Danzer, Markus Rechsteiner, et al.
Plos One|July 15, 2011
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerLotta von Boehmer, Lukas Keller, Ashkan Mortezavi, et al.
BMC Bioinformatics|January 3, 2023
Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathologyYauheniya Zhdanovich, Jörg Ackermann, Peter J Wild, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 14, 2015
Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancerBert-Ram Sah, Irene A Burger, Roger Schibli, et al.
Science Translational Medicine|September 14, 2018
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's diseaseLauren M Byrne, Filipe B Rodrigues, Eileanor B Johnson, et al.
Histopathology|February 27, 2024
Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinomaMaximilian N Kinzler, Falko Schulze, Jan Jeroch, et al.
Pageof 74